Appeal of electronic cigarettes in smokers with serious mental illness

Addictive Behaviors

Volumn 59, Issue , 2016, Pages 30-34

  Pratt, Sarah I ^a   Sargent, James ^a   Daniels, Luke ^a   Santos, Meghan M ^a   Brunette, Mary ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Electronic cigarettes; Serious mental illness; Smoking

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COUGHING; DIZZINESS; DRY THROAT; ELECTRONIC CIGARETTE; FEMALE; HUMAN; MALE; MENTAL DISEASE; NAUSEA; SELF REPORT; SERIOUS MENTAL ILLNESS; SMOKING; SMOKING CESSATION; SORE THROAT; TOBACCO DEPENDENCE; AGED; COMPLICATION; MIDDLE AGED; PATIENT SATISFACTION; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT SATISFACTION; SMOKERS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84962286566     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.03.009     Document Type: Article

References (49)

1. Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services 1998, 49(7):925-928.
2. Ayers J.W., Ribisl K.M., Brownstein J.S. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. American Journal of Preventive Medicine 2011, 40(4):448-453.
3. Baker A., Richmond R., Haile M., Lewin T.J., Carr V.J., Taylor R.L., Wilhelm K. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry 2006, 163(11):1934-1942. (Epub 2006/11/01; PubMed PMID: 17074945). 10.1176/appi.ajp.163.11.1934.
4. Barrington-Trimis J.L., Samet J.M., McConnell R. Flavorings in electronic cigarettes: An unrecognized respiratory health hazard?. Journal of the American Medical Association 2014, 312(23):2493-2494.
5. Benowitz N.L. Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics 2008, 83(4):531-541.
6. Birkenaes A.B., Opjordsmoen S., Brunborg C., et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study. The Journal of Clinical Psychiatry 2007, 68(6):917-923.
7. Breckenridge J.S. Smoking by outpatients. Hospital & Community Psychiatry 1990, 41(4):454-455.
8. Brown R.A., Burgess E.S., Sales S.D., Whiteley J.A., Evans D.M., Miller I.W. Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors 1998, 12(2):101.
9. Cahn Z., Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes?. Journal of Public Health Policy 2011, 32(1):16-31.
10. Caponnetto P., Auditore R., Russo C., Cappello G.C., Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: A prospective 12-month pilot study. International Journal of Environmental Research and Public Health 2013, 10(2):446-461.
11. Chou K., Chen R., Lee J., Ku C., Lu R. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies 2004, 41:321-330.
12. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006, 3(2):A42.
13. Cummins S.E., Zhu S.H., Tedeschi G.J., Gamst A.C., Myers M.G. Use of e-cigarettes by individuals with mental health conditions. Tobacco Control 2014, 23(Suppl. 3):iii48-iii53.
14. Currie S.R., Karltyn J., Lussier D., de Denus E., Brown D., El-Guebaly N. Outcome from a community-based smoking cessation program for persons with serious mental illness. Community Mental Health Journal 2008, 44(3):187-194. (Epub 2007/12/01; PubMed PMID: 18049896). 10.1007/s10597-007-9113-8.
15. Dale Horst W., Klein M.W., Willliams D., Werder S.F. Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neruopsychiatric Disease and Treatment 2005, 1(4):349-355.
16. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005, 76(2-3):135-157.
17. DH P., Correll C.U., Bobes J., et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World psychiatry 2011, 10(1):52-77.
18. Escobedo L.G., Peddicord J.P. Smoking prevalence in US birth cohorts: The influence of gender and education. American Journal of Public Health 1996, 86(2):231-236.
19. Evins A.E., Cather C., Culhane M.A., Birnbaum A., Horowitz J., Hsieh E., Goff D.C. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology 2007, 27(4):380-386. (Epub 2007/07/17; PubMed PMID: 17632223). 10.1097/01.jcp.0b013e3180ca86fa.
20. Farsalinos K.E., Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Therapeutic Advances in Drug Safety 2014, 5(2):67-86.
21. Farsalinos K.E., Tsiapras D., Kyrzopoulos S., Savvopoulou M., Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: Comparison with the effects of regular cigarettes. BMC Cardiovascular Disorders 2014, 14:78.
22. Farsalinos K.E., Spyrou A., Tsimopoulou K., Stefopoulos C., Romagna G., Voudris V. Nicotine absorption from electronic cigarette use: Comparison between first and new-generation devices. Scientific Reports 2014, 4:4133.
23. Flouris A.D., Poulianiti K.P., Chorti M.S., et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food and Chemical Toxicology 2012, 50(10):3600-3603.
24. Flouris A.D., Chorti M.S., Poulianiti K.P., et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhalation Toxicology 2013, 25(2):91-101.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
26. Foulds J., Veldheer S., Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. International Journal of Clinical Practice 2011, 65(10):1037-1042.
27. George T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., Kosten T.R. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. The American Journal of Psychiatry 2000, 157(11):1835-1842. (PMID: 11058482).
28. George T.P., Vessicchio J.C., Sacco K.A., Weinberger A.H., Dudas M.M., Allen T.M., Jatlow P.I. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry 2008, 63(11):1092-1096. (Epub 2007/12/22. doi: S0006-3223(07)01073-6; PubMed PMID: 18096137. 10.1016/j.biopsych.2007.11.002.
29. Glasheen C., Hedden S.L., Forman-Hoffman V.L., Colpe L.J. Cigarette smoking behaviors among adults with serious mental illness in a nationally representative sample. Annals of Epidemiology 2014, 24(10):776-780.
30. Goniewicz M.L., Knysak J., Gawron M., et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control 2014, 23(2):133-139.
31. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: A revision of the fagerstrom tolerance questionnaire. British Journal of Addiction 1991, 86(9):1119-1127.
32. Hummel K., Hoving C., Nagelhout G.E., et al. Prevalence and reasons for use of electronic cigarettes among smokers: Findings from the International Tobacco Control (ITC) Netherlands Survey. The International Journal on Drug Policy 2015, 26(6):601-608.
33. Hureaux J., Drouet M., Urban T. A case report of subacute bronchial toxicity induced by an electronic cigarette. Thorax 2014, 69(6):596-597.
34. Jensen R.P., Luo W., Pankow J.F., Strongin R.M., Peyton D.H. Hidden formaldehyde in e-cigarette aerosols. The New England Journal of Medicine 2015, 372(4):392-394.
35. Kalman D., Morissette S.B., George T.P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions. 2005, 14(2):106-123.
36. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association 2000, 284(20):2606-2610.
37. McCauley L., Markin C., Hosmer D. An unexpected consequence of electronic cigarette use. Chest 2012, 141(4):1110-1113.
38. McClave A.K., McKnight-Eily L.R., Davis S.P., Dube S.R. Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. American Journal of Public Health 2010, 100(12):2464-2472.
39. Pepper J.K., Emery S.L., Ribisl K.M., Rini C.M., Brewer N.T. How risky is it to use e-cigarettes? Smokers' beliefs about their health risks from using novel and traditional tobacco products. Journal of Behavioral Medicine 2015, 38(2):318-326.
40. Prochaska J.J., Grana R.A. E-cigarette use among smokers with serious mental illness. PloS One 2014, 9(11).
41. Rabinowitz J.D. Electronic cigarettes that produce nicotine aerosols substantially devoid of known toxic impurities. Paper presented at the Society of Nicotine and Tobacco Research, Seattle, WA 2014.
42. Regan A.K., Promoff G., Dube S.R., Arrazola R. Electronic nicotine delivery systems: Adult use and awareness of the 'e-cigarette' in the USA. Tobacco Control 2013, 22(1):19-23.
43. Sobell L.C., Sobell M.B. Timeline follow-back. Measuring alcohol consumption 1992, 41-72. Springer.
44. Sokal J., Messias E., Dickerson F.B., et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. The Journal of Nervous and Mental Disease. 2004, 192(6):421-427.
45. Vansickel A.R., Weaver M.F., Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012, 107(8):1493-1500.
46. Westenberger B. Evaluation of e-cigarettes 2009, 1-8. St Louis, MO, Food and Drug Administration.
47. Williams J.M., Steinberg M.L., Zimmermann M.H., Gandhi K.K., Stipelman B., Budsock P.D., Ziedonis D.M. Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. Journal of Substance Abuse Treatment 2010, 38(4):384-393. (Epub 2010/04/07; doi: S0740-5472(10)00067-X; PubMed PMID: 20363089). 10.1016/j.jsat.2010.03.006.
48. Zhu S.-H., Gamst A., Lee M., Cummins S., Yin L., Zoref L. The use and perception of electronic cigarettes and snus among the US population. PloS One 2013, 8(10).
49. Ziedonis D.M., George T.P. Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin 1997, 23(2):247-254.